iBio (IBIO) Leases (2019 - 2025)

iBio (IBIO) has disclosed Leases for 7 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases rose 818.23% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 818.23% increase, with the full-year FY2025 number at $2.1 million, down 14.58% from a year prior.
  • Leases was $1.9 million for Q4 2025 at iBio, down from $2.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $33.6 million in Q3 2021 to a low of $136000.0 in Q1 2025.
  • A 5-year average of $5.5 million and a median of $2.0 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: tumbled 99.45% in 2021, then surged 1867.81% in 2022.
  • iBio's Leases stood at $146000.0 in 2021, then soared by 1867.81% to $2.9 million in 2022, then crashed by 83.47% to $475000.0 in 2023, then tumbled by 57.26% to $203000.0 in 2024, then soared by 818.23% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Leases are $1.9 million (Q4 2025), $2.0 million (Q3 2025), and $2.1 million (Q2 2025).